August 28, 2025

Can Gene Therapy Outperform Implants?

Children receiving gene therapy showed superior hearing and speech perception metrics.

Conexiant

August 27, 2025

Fetal Brain Risks Tied to Common Analgesic

Using the Navigation Guide framework, researchers synthesized heterogeneous evidence on prenatal acetaminophen exposure, noting variability in study design, outcome measures, and potential confounding.

Conexiant

August 26, 2025

Recurrent Strokes, Headaches: What’s Your Diagnosis?

A 34-year-old woman presented with recurrent ischemic strokes and right-sided headaches. Magnetic resonance imaging revealed multiple right frontoparietal infarcts, and angiography demonstrated bilateral narrowing of the intracranial carotid arteries. What’s your diagnosis?

Conexiant

August 25, 2025

MacTel First

First commercial implantation of ENCELTO for idiopathic Macular Telangiectasia Type 2

The Ophthalmologist

August 25, 2025

Did Politics Delay CDC Measles Response?

Emails and interviews show CDC scientists were sidelined during the West Texas surge, leaving local officials without guidance as cases spread across the US and into Mexico.

KFF Health News

August 22, 2025

Pediatric CNS Tumors: Long-Term Survival and Cure Fraction Estimates

As reported in The Lancet Oncology by Hoogendijk et al, the EUROCARE-6 population-based study has provided long-term survival rates and cure fraction estimates for pediatric patients with central nerv...

The ASCO Post

August 20, 2025

Electroencephalography Measures Linked to Schizophrenia

Researchers link gamma-band power, alpha shifts to schizophrenia markers.

Conexiant

August 19, 2025

AAP Vaccine Recommendations Veer From ACIP

AAP released 2025 evidence-based US childhood and adolescent immunization schedule with updates for RSV, influenza, COVID-19, HPV, and meningococcal vaccines.

Conexiant

August 18, 2025

Early Risdiplam Use in Presymptomatic SMA Infants

Presymptomatic treatment with risdiplam was associated with improved motor development and survival without permanent ventilation in infants with spinal muscular atrophy (SMA), according to 24-month results from the phase 2 RAINBOWFISH trial published in the New England Journal of Medicine.

Conexiant